Definitive Contract 36C24421C0028

Award Date 3/24/21
Potential Completion Date 3/23/26
Potential Value $444K
Ultimate Awardee
Diasorin S.P.A.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15214, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract awarded to Diasorin Inc., a foreign-owned, for-profit organization, is a $10,213.90 firm fixed price delivery order placed by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network (VISN) 23. The contract is for the provision of Diasorin's diagnostic testing equipment, assays, reagents, and related services, which are critical to supporting healthcare operations across federal agencies including the VA, Department of Defense (DoD), and Department of...
This federal contract award is for the DIASORIN XL ANALYZER COST PER TEST IDIQ, awarded by the Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The $48,610 firm fixed-price contract provides the VA with access to Diasorin's LIAISON XL and LIAISON XS diagnostic testing equipment, along with associated reagents, consumables, and technical support services for infectious disease testing. This contract award is part of a larger Indefinite...
This is a federal contract award issued by the Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract, identified as DIASORIN XL ANALYZER COST PER TEST IDIQ ORDERING PERIOD 4, is a delivery order with a ceiling value of $87,485.00. It provides the VA's Veterans Integrated Service Network 21 with Diasorin's LIAISON XL chemiluminescence immunoassay analyzers, associated reagents, and related services for diagnostic testing,...
This federal contract award, valued at $90,000.00, was issued by the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit company specializing in diagnostic testing equipment and reagents. The contract is for the procurement of LIAISON XL testing equipment, which is used for a variety of infectious disease testing including COVID-19 and tuberculosis. Diasorin Inc. has a proven track record as a federal...
This federal contract award, valued at $188,257, was issued by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit company specializing in diagnostic testing equipment, assays, reagents, and related services. The contract is for DiaSorin LIAISON reagents and preventative maintenance, without any set-aside designation. Diasorin Inc. has a proven track record as a federal contractor, providing...
This federal contract award to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products, is for the delivery of COVID-19 tests and analyzers to the Veterans Integrated Service Network (VISN) 23 of the Department of Veterans Affairs (VA). The contract, valued at $498,757.12, is a Firm Fixed Price Delivery Order with a period of performance through September 30, 2023. This award is part of a larger $10 million single-award Indefinite Delivery Vehicle (IDV)...
This federal contract award to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment, was made by the U.S. Department of Veterans Affairs (VA) through Veterans Integrated Service Network (VISN) 23. The $169,000.00 Firm Fixed Price delivery order contract, which does not have a set-aside designation, is for the provision of COVID-19 tests and analyzers to support the VA's pandemic response and ongoing infectious disease testing...
This is a federal contract award to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company, by the Department of Veterans Affairs (VA). The contract, valued at $344,515.66, is for the delivery of reagents, testing, and leasing of equipment. It is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation. Diasorin Inc. is the prime contractor and is a subsidiary of the parent company Diasorin S.P.A. Diasorin has...
This is a delivery order issued under a federal contract awarded by the Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract is for the provision of advanced diagnostic testing equipment, assays, reagents, and related services to support the VA's medical operations. The contract, valued at $13,860.38, is a Firm Fixed Price Delivery Order with an ultimate completion date of September 30, 2025. Diasorin Inc. is the prime...
The Department of Veterans Affairs (VA) awarded a $146,011.47 firm-fixed-price purchase order to Diasorin Inc., a foreign-owned for-profit medical diagnostics company, for the maintenance and consumables support of LIAISON XL analyzers. The order supports healthcare operations at VA medical facilities and has a completion date of July 31, 2024. Diasorin Inc. is the U.S. subsidiary of the parent company Diasorin S.P.A., which holds several significant indefinite delivery vehicles with the VA...

This federal contract award, valued at $444,114.07, was issued by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract is a definitive, firm-fixed price agreement for the provision of an automated analyzer, assays, reagents, consumables, and technical support services to perform esoteric microbiology and virology immunoassay testing at the Pittsburgh VA Medical Center.

The original solicitation was a pre-solicitation notice that sought to acquire equipment and supplies to conduct routine testing for cytomegalovirus (CMV), Lyme disease, measles, mumps, rubella, and varicella zoster virus (VZV) through high-throughput chemiluminescent immunoassay (CLIA) testing. The contract has a one-year base period starting March 2021 with four one-year option periods. No set-aside designation was used for this acquisition.

Diasorin Inc. is a subsidiary of the parent company, Diasorin S.P.A., an Italy-based, for-profit manufacturer of medical diagnostic solutions. Diasorin has a strong track record of providing specialized diagnostic equipment and services to federal healthcare agencies like the VA, Department of Defense, and Department of Health and Human Services.

Generated 1/16/25, 9:04 AM